Stephen Berenson - Apr 4, 2024 Form 4 Insider Report for Seres Therapeutics, Inc. (MCRB)

Role
Director
Signature
/s/ Thomas J. DesRosier, Attorney-in-Fact
Stock symbol
MCRB
Transactions as of
Apr 4, 2024
Transactions value $
$0
Form type
4
Date filed
4/8/2024, 04:45 PM
Previous filing
Jun 23, 2023
Next filing
May 7, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MCRB Stock Option (Right to Buy) Award $0 +60K $0.00 60K Apr 4, 2024 Common Stock 60K $0.76 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in full on the earlier of April 4, 2025 or the day immediately prior to the company's 2025 annual meeting of shareholders.